Corient Capital Partners, LLC Idexx Laboratories Inc Transaction History
Corient Capital Partners, LLC
- $1.34 Billion
- Q3 2022
A detailed history of Corient Capital Partners, LLC transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Corient Capital Partners, LLC holds 3,420 shares of IDXX stock, worth $1.77 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
3,420
Previous 3,391
0.86%
Holding current value
$1.77 Million
Previous $1.19 Million
0.84%
% of portfolio
0.09%
Previous 0.09%
Shares
13 transactions
Others Institutions Holding IDXX
# of Institutions
1,259Shares Held
76MCall Options Held
129KPut Options Held
219K-
Vanguard Group Inc Valley Forge, PA9.86MShares$5.11 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$4.98 Billion0.11% of portfolio
-
State Street Corp Boston, MA3.65MShares$1.89 Billion0.06% of portfolio
-
Terry Smith Fundsmith LLP | London, X02.65MShares$1.37 Billion5.14% of portfolio
-
Geode Capital Management, LLC Boston, MA2.41MShares$1.25 Billion0.08% of portfolio
About IDEXX LABORATORIES INC
- Ticker IDXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 83,253,696
- Market Cap $43.1B
- Description
- IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...